x
ServiziMenu principaleHome
You are here: Home > About us > ESO core faculty > Haematologic Malignancies
Print

Haematologic Malignancies

Jane Apperley, Imperial College, Dept. of Haematology, London, United Kingdom
James O. Armitage, University of Nebraska Medical Center, Dept. of Oncology and Hematology, Omaha, USA
Dirk Arnold, CUF Hospitals Cancer Center, Dept. of Haematology and Oncology, Lisbon, Portugal
Ngwa Che Azinwi, Oncology Institue of Southern Switzerland (IOSI), Department of Radio-oncology, Bellinzona, Switzerland
Sally Barrington, St Thomas' Hospital, Nuclear Medicine PET Imaging Centre, London, United Kingdom
Francesco Bertoni, IOR Institute of Oncology Research, Lymphoma & Genomics Research Program, Bellinzona, Switzerland
Franco Cavalli, San Giovanni Hospital, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Luca Ceriani, Oncology Institute of Southern Switzerland (IOSI), Nuclear Medicine dpt., Bellinzona, Switzerland
Thomas Cerny, Cantonal Hospital, Dept. of Oncology/Haematology, St. Gallen, Switzerland
Matteo G. Della Porta, IRCCS Humanitas Research Hospital & Humanitas University    Cancer Center - Department of Hematology, Rozzano, Italy
Andrés J.M. Ferreri, San Raffaele Scientific Institute, Unit of Lymphoid Malignancies, Milano, Italy
Martin F. Fey, Universität Bern, Klinik Für Medizinische Onkologie, Berne, Switzerland
Michele Ghielmini, Oncology Institute of Southern Switzerland (IOSI), Div. of Medical Oncology, Bellinzona, Switzerland
Mary Gospodarowicz, Princess Margaret Cancer Center - University of Toronto, Dept. of Radiation Oncology, Toronto, Canada
Manuela A. Hoechstetter, Klinikum Schwabing, Klinik für Hämatologie, Onkologie, Immunologie, Palliativmed, Munich, Germany
Hussein Khaled, Cairo University, Dept. of Medical Oncology, Cairo, Egypt
Smruti Koppikar, Bombay Hospital Institute of Medical Sciences, Dept. of Medical Oncology, Mumbai, India
T. Andrew Lister, Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, St Bartholomew’s Hospital, London, United Kingdom
Heinz Ludwig, Wilhelminenspital, Dept. of Medicine and Medical Oncology, Vienna, Austria
Ian Magrath, INCTR Int. Network for Cancer Treatment and Research, President Office, Brussels, Belgium
Giampaolo Merlini, IRCCS Pilyclinic San Matteo Hospital, Biotechnology Research Laboratories, Amyloidosis Centre, Pavia, Italy
Blaise Nkegoum, University Hospital Center, Pathology and Oncology Dpt., Yaounde, Cameroon
Astrid Pavlovsky, Centro de Hematología Pavlovsky, Director Office, C.A. Buenos Aires, Argentina
Giancarlo Pruneri, University of Milan - IRCCS Foundation – National Cancer Institute, Dept. of Pathology - Biobank for Translational Medicine Dpt., Milan, Italy
John Seymour, Peter MacCallum Cancer Centre, Division of Cancer Medicine, Victoria, Australia
Anastasios Stathis, Oncology Institute of Southern Switzerland, Div. of Medical Oncology, Bellinzona, Switzerland
Stephan Stilgenbauer, University of Ulm, Dept. of Internal Medicine 3, Haematology and Oncology, Ulm, Germany
Julie M. Vose, University of Nebraska Medical Center, Division of Hematology/Oncology, Omaha, Nebraska, USA
Emanuele Zucca, Oncology Institute of Southern Switzerland, Div. of Medical Oncology, Bellinzona, Switzerland

Follow us